IL31289A - Pharmaceutical preparation containing a dermatologically active difluorinated corticoid and dithranol - Google Patents

Pharmaceutical preparation containing a dermatologically active difluorinated corticoid and dithranol

Info

Publication number
IL31289A
IL31289A IL31289A IL3128968A IL31289A IL 31289 A IL31289 A IL 31289A IL 31289 A IL31289 A IL 31289A IL 3128968 A IL3128968 A IL 3128968A IL 31289 A IL31289 A IL 31289A
Authority
IL
Israel
Prior art keywords
pharmaceutical preparation
preparation according
dithranol
corticoid
acetonide
Prior art date
Application number
IL31289A
Other languages
English (en)
Other versions
IL31289A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL31289A0 publication Critical patent/IL31289A0/xx
Publication of IL31289A publication Critical patent/IL31289A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL31289A 1968-01-08 1968-12-18 Pharmaceutical preparation containing a dermatologically active difluorinated corticoid and dithranol IL31289A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH19868 1968-01-08

Publications (2)

Publication Number Publication Date
IL31289A0 IL31289A0 (en) 1969-02-27
IL31289A true IL31289A (en) 1974-01-14

Family

ID=4181484

Family Applications (1)

Application Number Title Priority Date Filing Date
IL31289A IL31289A (en) 1968-01-08 1968-12-18 Pharmaceutical preparation containing a dermatologically active difluorinated corticoid and dithranol

Country Status (7)

Country Link
BE (1) BE726574A (hr)
DE (1) DE1817288A1 (hr)
FR (1) FR2000053A1 (hr)
GB (1) GB1225830A (hr)
IE (1) IE33109B1 (hr)
IL (1) IL31289A (hr)
NL (1) NL6900235A (hr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2565966B1 (fr) * 1984-06-13 1986-08-29 Cird Aryl-10 dihydroxy-1,8 anthrones et leurs esters, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
EP1205218B1 (de) * 2000-11-14 2004-03-31 Benkert, Eugen Georg, Dr.med.dent. Topical-Antipsoriaticum mit Harnstoff, einem Corticoid und einem Desinfektionsmittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070949A (en) * 1964-10-16 1967-06-07 Hyman Yarrow Topical compositions for the treatment of psoriasis

Also Published As

Publication number Publication date
BE726574A (hr) 1969-07-07
IE33109L (en) 1969-07-08
IE33109B1 (en) 1974-03-20
FR2000053A1 (fr) 1969-08-29
IL31289A0 (en) 1969-02-27
DE1817288A1 (de) 1969-08-07
GB1225830A (hr) 1971-03-24
NL6900235A (hr) 1969-07-10

Similar Documents

Publication Publication Date Title
US4083974A (en) Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
US4177267A (en) Enhancing tissue penetration of physiologically active steroidal agents with DMSC
DE2721831A1 (de) Entzuendungshemmende, topisch anzuwendende arzneipraeparate
CZ303142B6 (cs) Farmaceutický prostredek pro dermální použití
NO175350B (no) Fremgangsmåte for fremstilling av et topisk krempreparat for behandling av betennelse
US4048310A (en) Topical steroid formulation in form of lotion or cream
US4233295A (en) Corticosteroid formulations containing sebacate carrier
JPH0784382B2 (ja) 医薬組成物
US4370322A (en) Topically administrable pharmaceutical compositions containing anti-inflammatory steroids
EP0473811B1 (en) Ointment containing deprodone proprionate
US3529060A (en) Betamethasone 17-benzoate and its use as an anti-inflammatory
JPH0395120A (ja) 局所用スピロノラクトン組成物
US4473565A (en) Topical anti-inflammatory drug therapy
IL31289A (en) Pharmaceutical preparation containing a dermatologically active difluorinated corticoid and dithranol
US4299828A (en) Corticosteroid stick formulations
US3691214A (en) 17-valerate ester of 6alpha,9alpha-difluoroprednisolone,its compositions and use as an anti-inflammatory agent
US4279901A (en) Topical ointment
DE4344697A1 (de) Corticosteroide enthaltende W/O-Lotion
DE1643033B2 (de) 9 alpha, 11 beta-dichlor-16 alpha- methyl-1,4-pregnadien-17 alpha, 21-diol- 3,20-dion-17-ester verfahren zu ihrer herstellung und sie enthaltende therapeutische zubereitungen
US20030216364A1 (en) Dermatological Formulation
DE2154608A1 (de) Neues Diacetat, pharmazeutische Präparate und Herstellungsverfahren
DE2709078C2 (de) Neue Halogen-Derivate der Reihe des 16α-Methylpregnans, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2256129C3 (de) 17-Ester von 6α, 9α -Difluor-21-desoxyprednisolon, Verfahren zur Herstellung derselben sowie diese enthaltende Arzneimittel
GB2050831A (en) Corticosteroid stick formulations
EP1205218B1 (de) Topical-Antipsoriaticum mit Harnstoff, einem Corticoid und einem Desinfektionsmittel